UP AMERIPHARMA UNIPHARM GROUP

Serial Number 97593234
Registration 7395305
700

Registration Progress

Application Filed
Sep 15, 2022
Under Examination
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered
May 28, 2024

Trademark Image

UP AMERIPHARMA UNIPHARM GROUP

Basic Information

Serial Number
97593234
Registration Number
7395305
Filing Date
September 15, 2022
Registration Date
May 28, 2024
Published for Opposition
March 12, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 28, 2024
Registration
Registered
Classes
035

Rights Holder

Unipharm, Inc.

03
Address
Ste. 6701
350 Fifth Ave.
New York, NY 10118

Ownership History

Unipharm, Inc.

Original Applicant
03
New York, NY

Unipharm, Inc.

Owner at Publication
03
New York, NY

Unipharm, Inc.

Original Registrant
03
New York, NY

Legal Representation

Attorney
Eric Stenshoel

USPTO Deadlines

Next Deadline
1616 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240528)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 28, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 28, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 31, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 31, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 21, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 21, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2023 ALIE A ASSIGNED TO LIE Loading...
Jul 24, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 1, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 30, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Advertising services; business management in the field of pharmaceutical and food supplement manufacturing and distribution; business organization consultancy in the field of pharmaceutical and food supplement manufacturing and distribution; business administration in the field of pharmaceutical and food supplement manufacturing and distribution; office work in the nature of office administration services

Additional Information

Design Mark
The mark consists of the stylized black wording "AMERIPHARMA" above the stylized black words "UNIPHARM GROUP", all to the right of the stylized letters "U" and "P" in white and blue-green, inside a blue-green circle surrounded by a white circle, which is surrounded by a gray circle. The remaining white in the mark represents background and is not part of the mark.
Color Claim
The color(s) gray, blue-green, black and white is/are claimed as a feature of the mark.

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GROUP"